T
Tummanapalli Satyanarayana
Researcher at Singapore Science Park
Publications - 23
Citations - 2290
Tummanapalli Satyanarayana is an academic researcher from Singapore Science Park. The author has contributed to research in topics: Baylis–Hillman reaction & Enantiomeric excess. The author has an hindex of 11, co-authored 23 publications receiving 2137 citations. Previous affiliations of Tummanapalli Satyanarayana include University of Hyderabad & University of Paris-Sud.
Papers
More filters
Journal ArticleDOI
A novel, tandem construction of C–N and C–C bonds: facile and one-pot transformation of the Baylis–Hillman adducts into 2-benzazepines
TL;DR: A novel reaction involving tandem construction of C-N and C-C bonds via the simultaneous Ritter and Houben-Hoesch reactions on Baylis-Hillman adducts leading to a convenient, one-pot synthesis of 2-benzazepine derivatives is described.
Journal ArticleDOI
One-pot facile conversion of the acetates of Baylis–Hillman adducts into substituted fused pyrimidones in aqueous media
TL;DR: In this article, a facile, one-pot convenient transformation of the acetates of Baylis-Hillman adducts into fused pyrimidones, i.e. 3-substituted-1,5-diazabicyclo(4.4.0)deca-2,5,7,9-tetraen-4-ones via reaction with 2-aminopyridine in environmentally friendly aqueous media is described.
Journal ArticleDOI
The Multi-Substrate Screening of Asymmetric Catalysts
TL;DR: The principle of the one-pot multi-substrate screening is presented in this article, which has been successfully applied to various types of catalyzed enantioselective reactions: borane reduction of ketones, addition of organozinc on aldehydes, conjugate addition of diethylzinc on cycloalkenones or nitroal-kenes, hydroformylation of olefins, hetero-Diels-Al-der reaction on α-keto esters, enzymatic hydrolysis of glycerol
Journal ArticleDOI
The Baylis-Hillman reaction: one-pot stereoselective synthesis of methyl (2E)-3-aryl-2-hydroxymethylprop-2-enoates
TL;DR: In this article, a facile, simple and one-pot conversion of methyl 3-aryl-3-hydroxy-2-methylenepropanoates into methyl (2E)-3-yloyl trifluoromethanesulfonate (TMSOTf) and potassium carbonate/methanol is described.
Journal ArticleDOI
Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding Group
Christopher J. Bungard,Peter D. Williams,Jeanine E. Ballard,David Jonathan Bennett,Christian Beaulieu,Carolyn Bahnck-Teets,S S Carroll,Ronald K. Chang,Dubost David C,John F. Fay,Tracy L. Diamond,Thomas J. Greshock,Li Hao,M. Katharine Holloway,Peter J. Felock,Jennifer J. Gesell,Hua-Poo Su,Jesse J. Manikowski,Daniel J. McKay,Michael W. Miller,Xu Min,Carmela Molinaro,Oscar Miguel Moradei,Philippe G. Nantermet,Christian Nadeau,Rosa I. Sanchez,Tummanapalli Satyanarayana,William D. Shipe,Sanjay Kumar Singh,Vouy Linh Truong,Sivalenka Vijayasaradhi,Catherine M. Wiscount,Joseph P. Vacca,Sheldon Crane,John A. McCauley +34 more
TL;DR: A novel HIV protease inhibitor was designed using a morpholine core as the aspartate binding group, which afforded a series of potent orally bioavailable inhibitors of which MK-8718 was identified as a compound with a favorable overall profile.